Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.14%166.46B | 7.01%619.51B | 7.92%152.52B | 3.52%578.91B | 8.48%156.39B | -0.53%139.64B | -1.49%141.55B | 7.89%141.33B | 9.56%559.24B | 4.04%144.16B |
| Cost of revenue | 7.13%118.83B | 4.84%443.54B | 9.32%110.92B | 4.34%423.06B | 3.60%115.82B | -1.15%99.28B | 2.42%106.49B | 13.68%101.47B | 16.60%405.46B | 14.35%111.79B |
| Gross profit | 14.50%47.63B | 12.91%175.97B | 4.35%41.6B | 1.35%155.85B | 25.34%40.57B | 1.02%40.36B | -11.70%35.06B | -4.51%39.86B | -5.48%153.78B | -20.66%32.37B |
| Operating expense | -0.38%23.85B | 5.90%94.73B | 12.38%23.94B | 2.81%89.46B | 5.57%24.49B | 6.40%22.53B | -1.85%21.14B | 0.90%21.3B | 9.92%87.02B | 6.34%23.19B |
| Operating profit | 34.69%23.78B | 22.35%81.24B | -4.87%17.66B | -0.54%66.4B | 75.32%16.08B | -5.05%17.83B | -23.38%13.93B | -10.05%18.56B | -20.07%66.76B | -51.69%9.17B |
| Net non-operating interest income (expenses) | 55.26%-234M | 26.47%-1.78B | 19.66%-523M | 3.96%-2.43B | -272.11%-547M | 27.68%-567M | 17.91%-660M | 17.59%-651M | -26.50%-2.53B | -138.28%-147M |
| Non-operating interest income | 25.80%590M | 33.96%2.13B | 48.42%469M | 19.01%1.59B | -39.81%499M | 97.21%424M | 99.43%351M | 172.41%316M | -16.19%1.34B | -35.23%829M |
| Non-operating interest expense | -16.94%824M | -2.54%3.91B | 2.59%992M | 3.99%4.02B | 7.17%1.05B | -0.80%991M | 3.16%1.01B | 6.73%967M | 7.55%3.86B | 8.93%976M |
| Net investment income | 130.07%1.25B | -53.75%-1.66B | -9.67%542M | -153.25%-1.08B | -99.76%4M | 47.23%-514M | 2.82%-1.17B | -76.26%600M | -18.64%2.03B | 25.52%1.68B |
| Gain(Loss) on financial instruments designated as cash flow hedges | 35.42%-713M | 173.58%780M | 40.71%-1.1B | -417.07%-1.06B | 24.30%-1.38B | -53.66%1.59B | 220.37%585M | -38.96%-1.86B | 75.51%-205M | -271.98%-1.82B |
| Gain(Loss) on derecognition of available-for-sale financial assets | 4.77%483M | 31,310.00%3.12B | 2,326.32%461M | -100.76%-10M | 22.35%323M | 47.75%427M | -240.61%-779M | -90.73%19M | 13.01%1.31B | 528.57%264M |
| Income from associates and other participating interests | -98.34%26M | 110.68%41M | 2.96%1.57B | -5.55%1.53B | -65.00%35M | 5,385.71%384M | -85.51%-384M | -8.64%1.52B | -17.29%1.62B | |
| Special income (charges) | -275.97%-1.04B | 7.02%-7.1B | 341.04%591M | 32.89%-7.64B | 26.11%-7.24B | -116.28%-106M | 73.89%-430M | 122.64%134M | -471.69%-11.38B | -643.45%-9.79B |
| Less:Impairment of capital assets | ---- | 51.72%1.19B | ---- | 5.95%783M | ---- | ---- | ---- | ---- | 112.36%739M | ---- |
| Less:Other special charges | 107.11%42M | 191.35%95M | -341.04%-591M | -115.07%-104M | -176.56%-177M | 116.28%106M | -93.87%101M | 44.63%-134M | 115.10%690M | 98.06%-64M |
| Less:Write off | --998M | -16.38%5.82B | ---- | -30.07%6.96B | -27.29%6.63B | --0 | --329M | --0 | 758.67%9.95B | 697.03%9.12B |
| Other non-operating income (expenses) | 215.12%297M | -607.26%-2.17B | -84.29%-258M | 8,440.00%427M | 1,221.05%639M | -65.94%172M | 14.98%-244M | 10.26%-140M | -99.71%5M | -103.68%-57M |
| Income before tax | 36.86%23.82B | 28.98%72.46B | 6.94%17.41B | -2.34%56.18B | 914.66%9.42B | -14.23%18.88B | -18.88%11.61B | -19.74%16.28B | -36.66%57.52B | -96.37%928M |
| Income tax | -11.86%5.69B | 12.80%17.45B | 54.63%6.45B | 581.54%15.47B | 201.49%2.59B | 196.41%3.11B | -2.83%5.6B | 81.87%4.17B | -88.53%2.27B | -345.34%-2.55B |
| Net income | 65.53%18.14B | 35.14%55.01B | -9.48%10.96B | -26.33%40.7B | 96.01%6.82B | -37.53%15.76B | -29.69%6.01B | -32.70%12.11B | -22.22%55.25B | -85.81%3.48B |
| Net income continuous operations | 65.54%18.14B | 35.13%55.01B | -9.49%10.96B | -26.33%40.7B | 95.98%6.82B | -37.53%15.76B | -29.69%6.01B | -32.70%12.11B | -22.22%55.25B | -85.81%3.48B |
| Noncontrolling interests | 4,066.67%238M | -48.57%72M | -106.00%-6M | -30.69%140M | 101.47%137M | -37.61%68M | -5,600.00%-165M | 354.55%100M | 12.22%202M | 74.36%68M |
| Net income attributable to the company | 63.25%17.9B | 35.43%54.93B | -8.67%10.96B | -26.32%40.56B | 95.96%6.69B | -37.53%15.7B | -27.74%6.18B | -33.17%12.01B | -22.30%55.05B | -86.07%3.41B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 63.25%17.9B | 35.43%54.93B | -8.67%10.96B | -26.32%40.56B | 95.96%6.69B | -37.53%15.7B | -27.74%6.18B | -33.17%12.01B | -22.30%55.05B | -86.07%3.41B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 65.95%61.07 | 39.14%185.96 | -6.12%36.8 | -24.69%133.65 | 95.76%22.65 | -36.11%51.65 | -26.51%20.15 | -31.99%39.2 | -21.67%177.47 | -85.26%11.57 |
| Diluted earnings per share | 65.98%60.98 | 39.15%185.66 | -6.11%36.74 | -24.69%133.42 | 95.67%22.6 | -36.10%51.57 | -26.49%20.12 | -32.00%39.13 | -21.67%177.17 | -85.26%11.55 |
| Dividend per share | 0 | 20.00%60 | 0 | -24.24%50 | -24.24%25 | 0 | -24.24%25 | 0 | 4.76%66 | 0.00%33 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |